Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 15Lymphoid 3Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1729Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Lymphoma, Follicular 1067Lymphoma, Large B-Cell, Diffuse 1060Hodgkin Disease 906Leukemia 877Lymphoma, Mantle-Cell 738Leukemia, Myeloid, Acute 662Burkitt Lymphoma 604Multiple Myeloma 556Lymphoma, B-Cell, Marginal Zone 546Myelodysplastic Syndromes 507Recurrence 451Lymphoma, B-Cell 415Lymphoma, Large-Cell, Immunoblastic 328Waldenstrom Macroglobulinemia 323Lymphoma, T-Cell, Cutaneous 322Mycosis Fungoides 277Neoplasms 257Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Myeloproliferative Disorders 249Neoplasms, Plasma Cell 242Sezary Syndrome 231Leukemia, Myelogenous, Chronic, BCR-ABL Positive 221Lymphoma, Large-Cell, Anaplastic 215Leukemia, Myeloid, Accelerated Phase 211Lymphoma, T-Cell, Peripheral 205Blast Crisis 203

Interventions

Sodium Chloride 1Mesna 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-Related Cognitive Impairment × Lymphoid × Clear all
NCT07443514 2026-03-02

Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma

Institute of Oncology Ljubljana

Phase NA Recruiting
3 enrolled
Lymphoid

Chemotherapy-Related Cognitive Impairment, Lymphoma, Large B-Cell, Diffuse

NCT05840575 2023-05-03

MyBrain

Rigshospitalet, Denmark

Recruiting
100 enrolled
GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Chemotherapy-Related Cognitive Impairment, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Neoplasms, Sarcoma, Testicular Neoplasms

NCT01205503 2016-02-24

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

University of Kentucky

Phase 2 Completed
32 enrolled 24 charts
BreastLymphoid

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡